Insmed announces pricing of concurrent public offerings of common stock and convertible senior notes due 2028

Bridgewater, n.j., may 11, 2021 /prnewswire/ -- insmed incorporated (nasdaq: insm) announced today that it priced a registered underwritten public offering of 10,000,000 shares of its common stock (the "shares") at a price to the public of $25.00 per share before deducting underwriting discounts and commissions, and a registered underwritten public offering of $500 million aggregate principal amount of its 0.75% convertible senior notes due 2028 (the "notes").
INSM Ratings Summary
INSM Quant Ranking